Myeloid sarcoma: more and less than a distinct entity Giuseppe G. LoscoccoAlessandro M. Vannucchi Review Article Open access 07 June 2023 Pages: 1973 - 1984
Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia Xiao TangYin WangBei Liu Review Article 14 June 2023 Pages: 1985 - 1999
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma Yuan-hong HuangChao-Ling WanSheng-li Xue Review Article 25 May 2023 Pages: 2001 - 2013
Comparison of haploidentical–allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study Li-qiang WuLi-fang HuangJian-yong Li Review Article 17 May 2023 Pages: 2015 - 2023
Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000–2019) Evelyn Araujo CostaJackline de Paula Ayres-Silva Original Article Open access 26 May 2023 Pages: 2025 - 2031
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia Rafae El MabroukDalia Tawfeek HusseinSuzy Abd El Mabood Original Article 05 May 2023 Pages: 2033 - 2038
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia Vip ViprakasitMona M. HamdyAli T. Taher Original Article 25 May 2023 Pages: 2039 - 2049
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence Adam CukerBrian BuckleyJames B. Bussel Original Article Open access 10 June 2023 Pages: 2051 - 2058
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia Boris SorinJehane FadlallahLionel Galicier Original Article 29 June 2023 Pages: 2059 - 2068
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study Ignacio EspañolJuan Diego LealJosé M. Moraleda Original Article 12 May 2023 Pages: 2069 - 2075
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis Johannes LübkeNicole NaumannJuliana Schwaab Original Article Open access 04 April 2023 Pages: 2077 - 2085
Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution Chethan RPrabhat Singh MalikLalit Kumar Original Article 15 June 2023 Pages: 2087 - 2096
Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China Rongfeng FuHuan DongLei Zhang Original Article 24 June 2023 Pages: 2097 - 2107
Therapy results in pediatric Hodgkin lymphoma — does less mean better? Experience from a single children’s oncology center Joanna StankiewiczAndrzej KołtanJan Styczyński Original Article Open access 17 May 2023 Pages: 2109 - 2117
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group Anita SobońJoanna Drozd-SokołowskaBartosz Puła Original Article Open access 01 July 2023 Pages: 2119 - 2126
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study Tamar BergerTzippy ShochatRonit Gurion Original Article 19 June 2023 Pages: 2127 - 2136
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study M. MacroC. HulinX. Leleu Original Article Open access 10 June 2023 Pages: 2137 - 2151
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study Junnan LiXiaoqiong TangLi Yang Original Article 08 June 2023 Pages: 2153 - 2163
Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis Shyam SrinivasanSubramaniam RamanathanVenkatraman Radhakrishnan Original Article 08 May 2023 Pages: 2165 - 2179
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia Shenmiao YangNan LiXiaojun Huang Original Article 01 July 2023 Pages: 2181 - 2188
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma Liqin PingYan GaoHuiqiang Huang Original Article 12 June 2023 Pages: 2189 - 2198
Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia Isabella GruberOliver KoelblDaniel Wolff Original Article Open access 22 June 2023 Pages: 2199 - 2211
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome Alessia FraccaroliDaniela VogtJohanna Tischer Original Article Open access 10 June 2023 Pages: 2213 - 2223
Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning Agathe VelyJérôme PaillassaCorentin Orvain Original Article 28 June 2023 Pages: 2225 - 2231
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) Mihee KimJe-Jung LeeSung-Hoon Jung Original Article 01 July 2023 Pages: 2233 - 2240
Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission Wen-Jing YuYu-qian SunYu Wang Original Article 21 June 2023 Pages: 2241 - 2250
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration Lengnan XuYing SunYonghui Mao Original Article Open access 03 July 2023 Pages: 2251 - 2256
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study Jing LiYou ZhangFang Huang Original Article 14 June 2023 Pages: 2257 - 2265
Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data Riccardo MasettiEdoardo MuratoreFranco Locatelli Letter to the Editor 15 April 2023 Pages: 2267 - 2270
Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report Ning YuXiaojun LiuYa Liu Letter to the Editor 06 May 2023 Pages: 2271 - 2273
Myomatous erythrocytosis syndrome—an uncommon cause of secondary polycythemia Mariana de Oliveira MarquesNatalia Campos GomesAlex Freire Sandes Letter to the Editor 20 March 2023 Pages: 2275 - 2276
Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation Khaled M. MusallamWesam AhmedShahrukh Hashmi Letter to the Editor 10 May 2023 Pages: 2277 - 2278
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version Marina BeliaIoannis DrandakisTheodoros P. Vassilakopoulos Letter to the Editor 28 April 2023 Pages: 2279 - 2282
Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient Julia Bini ViottiFabian DammannMohammed Raja Letter to the Editor 15 May 2023 Pages: 2283 - 2284
CD200 expression in T cell neoplasms Renata Bartolomeu StaubNatália Aydos MarcondesLiane Nanci Rotta Letter to the Editor 11 May 2023 Pages: 2285 - 2286
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation Zhimin LinYanjun WuFeng Chen Letter to the Editor Open access 13 May 2023 Pages: 2287 - 2289
Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy Yutaka ShimazuChisaki MizumotoAkifumi Takaori-Kondo Letter to the Editor 27 April 2023 Pages: 2291 - 2292
An adult case of systemic lupus erythematosus and cerebral vasculitis after umbilical cord blood transplantation for acute myeloid leukemia Weiwei XieZeyin LiangYujun Dong Letter to the Editor 01 May 2023 Pages: 2293 - 2295
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation Massimo MartinoMercedes GoriAnnalisa Pitino Correction Open access 22 June 2023 Pages: 2297 - 2298
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States Amer M. ZeidanDaniel A. PollyeaClara Chen Correction Open access 21 June 2023 Pages: 2299 - 2299
